Dear Representative: Support $20 million in Senate Level Defense-Funded Melanoma Research for Fiscal Year 2020
Earlier this year, Representative Carolyn Maloney led a letter signed by 21 Members of the House to the House Defense Appropriations Subcommittee requesting that the Subcommittee provide $20 million for the PRMRP in its Fiscal 2020 Defense Appropriations bill. The House Appropriations Committee included instead $10 million for the PRMRP, the same as the Fiscal 2019 level for the program.
Earlier this month, the Senate approved $20 million for Defense-funded melanoma research for Fiscal 2020, and now, We NEED YOUR HELP in ensuring the House supports Senate level funding!
Please contact your Representative to support $20 million in Senate level Defense-funded melanoma research by co-sponsoring Representative Carolyn Maloney's letter to the House Appropriations Committee urging them to approve $20 million in Defense-funded melanoma research! The window for support has been extended to Thursday,October 31!
Defense-funded melanoma prevention and research programs have positively impacted the lives of millions of Americans.
Here are the facts based on 10-year surveillance from 2005 through 2014:
- Among male service members, malignant melanoma was one of the most frequent cancer diagnosis
- Among females, malignant melanoma was the second most frequent cancer diagnosis
- A 2014 Military Medicine Study found that the overall incidence rate of melanoma in active duty military personnel between 2000 and 2007 was 62% greater than among the general population
- According to the online journal of Uniformed Services University, “melanoma is the most significant cancer to affect the active-duty military population."
- Melanoma is the deadliest form of skin cancer. Skin cancer is the most common form of cancer in the US
Dear Representative: Support $20 million in Senate Level Defense-Funded Melanoma Research for Fiscal Year 2020
Earlier this year, Representative Carolyn Maloney led a letter signed by 21 Members of the House to the House Defense Appropriations Subcommittee requesting that the Subcommittee provide $20 million for the PRMRP in its Fiscal 2020 Defense Appropriations bill. The House Appropriations Committee included instead $10 million for the PRMRP, the same as the Fiscal 2019 level for the program.
Earlier this month, the Senate approved $20 million for Defense-funded melanoma research for Fiscal 2020, and now, We NEED YOUR HELP in ensuring the House supports Senate level funding!
Please contact your Representative to support $20 million in Senate level Defense-funded melanoma research by co-sponsoring Representative Carolyn Maloney's letter to the House Appropriations Committee urging them to approve $20 million in Defense-funded melanoma research! The window for support has been extended to Thursday,October 31!
Defense-funded melanoma prevention and research programs have positively impacted the lives of millions of Americans.
Here are the facts based on 10-year surveillance from 2005 through 2014:
- Among male service members, malignant melanoma was one of the most frequent cancer diagnosis
- Among females, malignant melanoma was the second most frequent cancer diagnosis
- A 2014 Military Medicine Study found that the overall incidence rate of melanoma in active duty military personnel between 2000 and 2007 was 62% greater than among the general population
- According to the online journal of Uniformed Services University, “melanoma is the most significant cancer to affect the active-duty military population."
- Melanoma is the deadliest form of skin cancer. Skin cancer is the most common form of cancer in the US